Close
MyNorthwest
News
Opinion
Sports
Tools
Connect

New guidance: Use drugs, surgery early for obesity in kids

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. Children struggling with obesity should be evaluated and treated early and aggressively, with medications for kids as young as 12 and surgery for those as young as 13 who qualify, according to new guidelines released by the American Academy of Pediatrics on Monday, Jan. 9, 2023. A study published in the New England Journal of Medicine in December 2022, found that Wegovy helped teens reduce their body mass index by about 16% on average, better than the results in adults. (Novo Nordisk via AP) This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. Children struggling with obesity should be evaluated and treated early and aggressively, with medications for kids as young as 12 and surgery for those as young as 13 who qualify, according to new guidelines released by the American Academy of Pediatrics on Monday, Jan. 9, 2023. A study published in the New England Journal of Medicine in December 2022, found that Wegovy helped teens reduce their body mass index by about 16% on average, better than the results in adults. (Novo Nordisk via AP) This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. Children struggling with obesity should be evaluated and treated early and aggressively, with medications for kids as young as 12 and surgery for those as young as 13 who qualify, according to new guidelines released by the American Academy of Pediatrics on Monday, Jan. 9, 2023. A study published in the New England Journal of Medicine in December 2022, found that Wegovy helped teens reduce their body mass index by about 16% on average, better than the results in adults. (Novo Nordisk via AP) This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. Children struggling with obesity should be evaluated and treated early and aggressively, with medications for kids as young as 12 and surgery for those as young as 13 who qualify, according to new guidelines released by the American Academy of Pediatrics on Monday, Jan. 9, 2023. A study published in the New England Journal of Medicine in December 2022, found that Wegovy helped teens reduce their body mass index by about 16% on average, better than the results in adults. (Novo Nordisk via AP) This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. Children struggling with obesity should be evaluated and treated early and aggressively, with medications for kids as young as 12 and surgery for those as young as 13 who qualify, according to new guidelines released by the American Academy of Pediatrics on Monday, Jan. 9, 2023. A study published in the New England Journal of Medicine in December 2022, found that Wegovy helped teens reduce their body mass index by about 16% on average, better than the results in adults. (Novo Nordisk via AP) This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. Children struggling with obesity should be evaluated and treated early and aggressively, with medications for kids as young as 12 and surgery for those as young as 13 who qualify, according to new guidelines released by the American Academy of Pediatrics on Monday, Jan. 9, 2023. A study published in the New England Journal of Medicine in December 2022, found that Wegovy helped teens reduce their body mass index by about 16% on average, better than the results in adults. (Novo Nordisk via AP) This image provided by Novo Nordisk shows packaging for the company's Wegovy drug. Children struggling with obesity should be evaluated and treated early and aggressively, with medications for kids as young as 12 and surgery for those as young as 13 who qualify, according to new guidelines released by the American Academy of Pediatrics on Monday, Jan. 9, 2023. A study published in the New England Journal of Medicine in December 2022, found that Wegovy helped teens reduce their body mass index by about 16% on average, better than the results in adults. (Novo Nordisk via AP) This image provided by Novo Nordisk shows packaging for the company's Wegovy drug. Children struggling with obesity should be evaluated and treated early and aggressively, with medications for kids as young as 12 and surgery for those as young as 13 who qualify, according to new guidelines released by the American Academy of Pediatrics on Monday, Jan. 9, 2023. A study published in the New England Journal of Medicine in December 2022, found that Wegovy helped teens reduce their body mass index by about 16% on average, better than the results in adults. (Novo Nordisk via AP)
New guidance: Use drugs, surgery early for obesity in kids